Conditions: Thromboembolism
Keywords: Xa factor VTE MOSLL pentasaccharide
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 48
Healthy volunteers: no

Brief summary:
This study is requested by PMDA to confirm the efficacy and the safety for HFS.

Detailed description:

Arms:

Interventions: intervention 1: Fondaparinux
Intervention descriptions: intervention 1: None

Protocol document: